DNAJC8:肝细胞癌的预后标记物和潜在的治疗标
Zhibo Zhang1, Mingxiu Ju1, Zhongming Tang1
1Department of Radiation Oncology, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, China.
Frontiers in immunology
|January 26, 2024
概括
DnaJ热冲击蛋白家族成员C8 (DNAJC8) 在肝癌 (HCC) 中被上调,并促进瘤生长. DNAJC8可能成为HCC患者的新治疗标和预后标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是肝癌的主要形式.
- DnaJ热冲击蛋白家族成员C8 (DNAJC8),热冲击蛋白40 (HSP40) 家庭成员,影响癌症生物学.
- DNAJC8在HCC发育中的特定作用以前没有被描述.
研究的目的:
- 研究DNAJC8在HCC中的表达和临床意义.
- 阐明DNAJC8在HCC发育中的生物学功能.
主要方法:
- 使用癌症基因组图谱,GTEx,cBioPortal和人类蛋白质图谱分析DNAJC8表达和临床数据.
- 在HCC细胞系 (MHCC-97H和Huh-7) 的功能性研究涉及DNAJC8敲击.
主要成果:
- DNAJC8表达在HCC组织中升高,并与较差的临床结果有关.
- DNAJC8与结合体,核细胞质运输和细胞循环途径有关,可能有助于免疫抑制瘤微环境.
- 降低DNAJC8水平显著损害了HCC细胞的增殖和诱导的亡.
结论:
- DNAJC8 在HCC中充当瘤基因.
- DNAJC8具有作为肝细胞癌治疗标和预后生物标记物的潜力.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
